PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
02-Nov-2023 AbCellera Reports Q3 2023 Business Results Businesswire
02-Nov-2023 Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2023 Financial Results Businesswire
02-Nov-2023 Prothena Reports Third Quarter 2023 Financial Results and Business Highlights Businesswire
02-Nov-2023 Puma Biotechnology Reports Third Quarter 2023 Financial Results Businesswire
02-Nov-2023 Insulet Reports Third Quarter 2023 Revenue Increase of 27% Year-Over-Year (25% Constant Currency1) Businesswire
02-Nov-2023 Pathway to Cures Announces Inaugural Fund Update Businesswire
02-Nov-2023 El Committee to Restore Nymox Shareholder Value recuerda a todos los accionistas de Nymox Pharmaceutical que actúen y exijan responsabilidades en la próxima asamblea extraordinaria del 8 de noviembre Businesswire
02-Nov-2023 MaaT Pharma Announces Two Poster Presentations for MaaT013 and MaaT033 at the Upcoming ASH Conference Businesswire
02-Nov-2023 New Data for ADCETRIS® (brentuximab vedotin) with Immunotherapy Combination in Hodgkin Lymphoma to be Featured at 2023 ASH Annual Meeting, and Seagen to Unveil Novel CD30-Directed Antibody-Drug Conjugate Businesswire
02-Nov-2023 New England Journal of Medicine Publishes Complete Results of Positive Phase 2 Trial of Sibeprenlimab in Treatment of Immunoglobulin A Nephropathy (IgAN) Businesswire
02-Nov-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of MaxLinear, Inc. (MXL) on Behalf of Investors Businesswire
02-Nov-2023 Technological Advancements and Rising R&D Investments Drive the Global Cleanroom Facility Market to Reach $103.72 Billion by 2028 - ResearchAndMarkets.com Businesswire
02-Nov-2023 Provectus Algae Enters Into Livestock Methane Reduction Space Commissioning First Demonstration Biomanufacturing Plant Businesswire
02-Nov-2023 The Hackett Group: U.S. Companies See Worsening Performance Of Payables, Collections and Inventory in Q2 2023 Businesswire
02-Nov-2023 Presentations at MPN Congress and ASH Annual Meeting Reinforce Clinical Role of ropeginterferon alfa-2b-njft Businesswire
02-Nov-2023 Electra Therapeutics to Present Clinical Data for ELA026 at the American Society of Hematology (ASH) 2023 Annual Meeting Businesswire
02-Nov-2023 Legend Biotech to Showcase Leadership in Multiple Myeloma Treatment at the ASH 2023 Annual Meeting Businesswire
02-Nov-2023 Rallybio Announces Acceptance of FNAIT Natural History Study Abstract for Presentation at the 65th American Society of Hematology Annual Meeting Businesswire
02-Nov-2023 Genmab Announces Multiple Abstracts to be Presented at the 65th Annual Meeting and Exposition of the American Society of Hematology (ASH) Businesswire
02-Nov-2023 Vertex to Present New Data on Exagamglogene Autotemcel (exa-cel) at the American Society of Hematology (ASH) Annual Meeting and Exposition Businesswire